OpenEvidence reportedly valued at $15 billion in new funding round
Business Insider says the startup has raised nearly $800 million over the past year, with Nvidia, Thrive Capital, Kleiner Perkins, a16z and Sequoia Capital among its investors.
TLDR
Business Insider reports that OpenEvidence, described as “ChatGPT for doctors,” was valued at $15 billion in a new funding round. It says the startup has raised nearly $800 million over the past year. A post sharing the report says OpenEvidence could also be open to a merger or acquisition deal that includes access to computing resources, due to rising anti-AI backlash.
OpenEvidence reportedly valued at $15 billion in new funding round
Business Insider says the startup has raised nearly $800 million over the past year, with Nvidia, Thrive Capital, Kleiner Perkins, a16z and Sequoia Capital among its investors.